TUCSON,
Ariz., Oct. 25, 2024 /PRNewswire/ -- Accelerate
Diagnostics, Inc. (NASDAQ: AXDX) announced that management will
host a conference call Thursday, November 7,
2024, at 4:30 p.m. Eastern
Time to review 2024 third quarter results.
To listen to the audio webcast online, visit ir.axdx.com. A
replay of the audio webcast will be available for 30 days.
To listen by phone, dial +1.877.883.0383 and enter the Elite
Entry Number: 1269422. International participants may dial
+1.412.902.6506. Please dial in 10-15 minutes prior to the start of
the conference.
A replay of the call will be available by telephone at
+1.877.344.7529 (U.S.) or +1.412.317.0088 (International) using the
replay code 2603705 until November 28, 2024.
About Accelerate Diagnostics, Inc.
Accelerate Diagnostics, Inc. is an in vitro diagnostics company
dedicated to providing solutions for the global challenges of
antibiotic resistance and sepsis. In addition to the Accelerate Arc
system, the Accelerate Pheno system and Accelerate PhenoTest® BC
kit combine several technologies aimed at reducing the time
clinicians must wait to determine the most optimal antibiotic
therapy for deadly infections. The FDA-cleared Accelerate Pheno
system and Accelerate PhenoTest BC kit fully automate sample
preparation, identification and phenotypic antibiotic
susceptibility testing in approximately seven hours directly from
positive blood cultures. Recent external studies indicate the
solution offers results 1–2 days faster than existing methods,
enabling clinicians to optimize antibiotic selection and dosage
specific to the individual patient days earlier. The FDA-cleared
Accelerate Arc and BC kit platform is an automated positive blood
culture sample preparation platform for use with Bruker's MALDI
Biotyper® CA System (MBT-CA System) and MBT-CA Sepsityper® software
extension.
© Copyright 2024 Accelerate Diagnostics, Inc. All Rights
Reserved. The "ACCELERATE DIAGNOSTICS," "ACCELERATE PHENO,"
"ACCELERATE PHENOTEST," "ACCELERATE ARC" and "ACCELERATE WAVE"
diamond shaped logos and marks are trademarks or registered
trademarks of Accelerate Diagnostics, Inc. All other trademarks are
the property of their respective owners.
For more information about the company, its products and
technology, or recent publications, visit axdx.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/accelerate-diagnostics-scheduled-call-to-review-2024-third-quarter-results-302287696.html
SOURCE Accelerate Diagnostics, Inc.